Table 1: CLINICAL CHARACTERISTICS OF ILE416THR CARRIERS AND NON-CARRIERS.
Non-carriers | Ile416Thr carriers | ||||
---|---|---|---|---|---|
Total n= 67 | Total n= 26 | Asymptomatic n=14 | MCI n=4 | Dementia n=8 | |
Age at onset | NA | NA | NA | 47.6 (5.8) | 51.6 (5.0) |
Age at evaluation | 36.5 (14.3) | 46.0 (14.4) | 36.5 (12.0) | 50.8 (3.8) | 59.1 (8.7) |
CDR | |||||
0 (None) | 63 (94%) | 14 (53,9%) | 14 (100%) | 0 | 0 |
0.5 (Questionable) | 4 (6%) | 4 (15.4%) | 0 | 4 (100%) | 0 |
1 (Mild) | 0 | 3 (11.5%) | 0 | 0 | 3 (37.5%) |
2 (Moderate) | 0 | 2 (7.7%) | 0 | 0 | 2 (25%) |
3 (Severe) | 0 | 3 (11.5%) | 0 | 0 | 3 (37.5%) |
Depression symptoms | 7 (10.4%) | 8 (30,8%) | 1 (7.1%) | 1 (25%) | 6 (75%) |
Anxiety symptoms | 0 | 6 (23,1%) | 1 (7.1%) | 1 (25%) | 4 (50%) |
Delusions | 0 | 3 (11.5%) | 0 | 1 (25%) | 2 (25%) |
Hallucinations | 0 | 3 (11.5%) | 0 | 1 (25%) | 2 (25%) |
Insomnia | 0 | 4 (15.4%) | 0 | 1 (25%) | 3 (37.5%) |
NPI-Q median (IR) | 0 (4) | 2,00 (10,50) | 0,00 (6,25) | 9,5 (21,00) | 41(NA) |
Myoclonus | 0 | 5 (19.2%) | 0 | 0 | 5 (62.5%) |
Seizures | 0 | 4 (15.4%) | 0 | 0 | 4 (50%) |
Traumatic Brain Injury | 9 (13,4%) | 2 (7.7%) | 1 (7.1%) | 1 (25%) | 0 |
Headache | 0 | 4 (15.4%) | 1 (7.1%) | 2 (50%) | 1 (12.5%) |
Alcoholism | 2 (3%) | 4 (15.4%) | 1 (7.1%) | 0 | 3 (37.5%) |
Tobacco use | 14 (20,9%) | 11 (42.3%) | 5 (35.7%) | 2 (50%) | 4 (50%) |
Drug abuse | 6 (9%) | 2 (7.7%) | 2 (14.3%) | 0 | 0 |
Learning difficulties | 11 (16.4%) | 4 (15.4%) | 3 | 1 | 0 |